Balyasny Asset Management L.P. and related reporting persons filed an amended Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 572,533 shares of common stock in Korsana Biosciences, Inc. as of September 30, 2026.
Key Highlights
- Aggregate beneficial ownership: Each of the five reporting persons is reported as beneficially owning 572,533 shares of Korsana Biosciences common stock, no par value per share.
- Percent of class: The 572,533 shares represent approximately 1.26% of outstanding shares, based on 45,541,425 shares outstanding as of September 8, 2026.
- Sole voting and dispositive power: Each reporting person holds sole power to vote and to dispose of all 572,533 shares, with zero shared voting or dispositive power reported.
- Direct holders: The shares are held directly by Atlas Private Holdings (Cayman) Ltd. (570,064 shares) and Atlas Diversified Master Fund, Ltd. (2,469 shares), both investment management clients of Balyasny Asset Management L.P.
- Reporting persons: The five filers are Balyasny Asset Management L.P., BAM GP LLC, Balyasny Asset Management Holdings LP, Dames GP LLC, and Dmitry Balyasny, all headquartered at 444 West Lake Street, 50th Floor, Chicago, IL 60606.
- Triggering event date: The date of the event requiring this filing is stated as September 30, 2026.
Balyasny Asset Management's Amended 13G Position in Korsana Biosciences
According to the filing, Balyasny Asset Management L.P. ("BAM"), a Delaware limited partnership serving as investment manager, may be deemed to exercise voting and investment power over shares held directly by two Cayman Islands exempted companies: Atlas Private Holdings (Cayman) Ltd., which directly holds 570,064 shares, and Atlas Diversified Master Fund, Ltd., which directly holds 2,469 shares. The combined total of 572,533 shares forms the aggregate beneficial ownership figure reported by each of the five reporting persons.
The filing describes a chain of control in which BAM GP LLC serves as the general partner of BAM; Balyasny Asset Management Holdings LP is the sole member of BAM GP LLC; Dames GP LLC is the general partner of BAM Holdings; and Dmitry Balyasny, a United States citizen, is the managing member of Dames GP LLC. As a result, each entity and individual in the chain is reported as beneficially owning the same 572,533 shares, all with sole voting and sole dispositive power and no shared voting or dispositive power.
The percent-of-class figure of 1.26% is based on 45,541,425 shares of common stock outstanding as of September 8, 2026, as reported in Korsana Biosciences' Form 8-K filed with the SEC on September 11, 2026, according to the Schedule 13G. The filing identifies Item 5 as applicable, noting ownership of 5 percent or less of the class. The issuer, Korsana Biosciences, Inc., is located at 203 Crescent Street, Bldgs. #3/3A/4, Suite 503, Waltham, Massachusetts, 02453. The filing does not name an exchange or ticker symbol in the cover or body text reviewed.
What Was Disclosed
Balyasny Asset Management L.P. and four affiliated entities and individuals filed an amended Schedule 13G disclosing aggregate beneficial ownership of 572,533 shares, equal to approximately 1.26%, of Korsana Biosciences, Inc. common stock as of September 30, 2026.




Please wait processing your request...